Exact Sciences
EXAS
#1106
Rank
A$30.19 B
Marketcap
A$158.20
Share price
0.00%
Change (1 day)
90.81%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$8.02. In 2024 the company made an earnings per share (EPS) of A-$8.40.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.541.67%
2024A-$8.40
2022A-$5.342.31%
2021A-$5.22-38.54%
2020A-$8.49692.96%
2019A-$1.07-50.69%
2018A-$2.1744%
2017A-$1.51-39.39%
2016A-$2.49-2.94%
2015A-$2.5637.1%
2014A-$1.8779.71%
2013A-$1.04-21.59%
2012A-$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.99-137.23%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$2.40-129.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.51-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$2.05-74.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$76.76 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA